Renaissance Technologies - BIOSTAR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of BIOSTAR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$468,000
+134.0%
105,956
+1.0%
0.00%
Q1 2016$200,000104,8560.00%
Other shareholders
BIOSTAR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 2,000$9,0000.01%
Renaissance Technologies 105,956$468,0000.00%
UBS Group AG 4,793$21,0000.00%
BANK OF AMERICA CORP /DE/ 143$1,0000.00%
DEUTSCHE BANK AG\ 2$00.00%
CREDIT SUISSE AG/ 29,116$129,0000.00%
MORGAN STANLEY 24$00.00%
JANE STREET GROUP, LLC 15,556$69,0000.00%
View complete list of BIOSTAR PHARMACEUTICALS INC shareholders